Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Andersen

Showing results (141-150 of 241) with videos related to

Pageof 25
Sort By:
Human Molecular Genetics|February 9, 2017
Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosisYasuyuki Ohta, Genevieve Soucy, Daniel Phaneuf, et al.
Human Molecular Genetics|May 19, 2012
Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALSMatthis Synofzik, Dario Ronchi, Isil Keskin, et al.
Neurobiology of Disease|September 25, 2002
CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigreesP Andreas Jonsson, Asa Bäckstrand, Peter M Andersen, et al.
Archives of Neurology|January 14, 2009
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosisBiba R Stanton, Daisy Shinhmar, Martin R Turner, et al.
Communications Medicine|July 25, 2024
Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patientsJochen H Weishaupt, Péter Körtvélyessy, Peggy Schumann, et al.
Neurology|July 28, 2025
Proposed Research Criteria for Mild Motor Impairment as a Prodromal Syndrome in Amyotrophic Lateral SclerosisMichael Benatar, Xueya Cai, Michael P McDermott, et al.
Neurobiology of Disease|September 6, 2011
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effectSuzana Gispert, Alexander Kurz, Stefan Waibel, et al.
Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 26, 2003
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputesPeter M Andersen, Katherine B Sims, Winnie W Xin, et al.
Neurobiology of Aging|September 22, 2018
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanismsAntonio Canosa, Giovanni De Marco, Annarosa Lomartire, et al.
Pageof 25

Showing results (141-150 of 241) with videos related to

Sort By:
Pageof 25
Human Molecular Genetics|February 9, 2017
Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosisYasuyuki Ohta, Genevieve Soucy, Daniel Phaneuf, et al.
Human Molecular Genetics|May 19, 2012
Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALSMatthis Synofzik, Dario Ronchi, Isil Keskin, et al.
Neurobiology of Disease|September 25, 2002
CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigreesP Andreas Jonsson, Asa Bäckstrand, Peter M Andersen, et al.
Archives of Neurology|January 14, 2009
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosisBiba R Stanton, Daisy Shinhmar, Martin R Turner, et al.
Communications Medicine|July 25, 2024
Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patientsJochen H Weishaupt, Péter Körtvélyessy, Peggy Schumann, et al.
Neurology|July 28, 2025
Proposed Research Criteria for Mild Motor Impairment as a Prodromal Syndrome in Amyotrophic Lateral SclerosisMichael Benatar, Xueya Cai, Michael P McDermott, et al.
Neurobiology of Disease|September 6, 2011
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effectSuzana Gispert, Alexander Kurz, Stefan Waibel, et al.
Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 26, 2003
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputesPeter M Andersen, Katherine B Sims, Winnie W Xin, et al.
Neurobiology of Aging|September 22, 2018
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanismsAntonio Canosa, Giovanni De Marco, Annarosa Lomartire, et al.
Pageof 25